# Taking a GLP-1 Like Ozempic? These Health Risks Are Higher in the Heat
Parents using GLP-1 medications like Ozempic, Wegovy, or Mounjaro need to take extra precautions during summer months. Heat intensifies several health risks tied to these popular weight-loss and diabetes drugs.
GLP-1 receptor agonists work by slowing gastric emptying and reducing appetite. This mechanism becomes problematic in hot weather. The medications impair your body's ability to regulate temperature and maintain hydration. Combined with summer heat, users face elevated risk of dehydration, heat exhaustion, and heat stroke.
The drugs also affect blood sugar control differently in heat. High temperatures can increase insulin absorption rates, potentially triggering low blood sugar episodes in diabetic users. Heat also affects how your body processes the medication itself, changing drug effectiveness.
Nausea accompanies GLP-1 use for many patients. Heat amplifies nausea and reduces appetite further, making it harder to eat and drink enough. Proper nutrition and hydration become critical yet challenging during summer.
Healthcare providers recommend several protective steps. Drink water consistently throughout the day, not just when thirsty. Your thirst response becomes unreliable on GLP-1s. Avoid prolonged sun exposure and spend time in air-conditioned spaces when possible. Check blood sugar more frequently if you take insulin or other diabetes medications alongside GLP-1s.
Never store GLP-1 pens in direct sunlight or hot cars. Most require refrigeration or specific temperature ranges. Heat damage compromises the medication's stability and effectiveness.
Parents managing their own GLP-1 use should discuss summer safety with their prescribing doctor before warm weather hits. Your doctor may adjust dosing or monitoring schedules. Emergency room visits for heat-related illness